Literature DB >> 21982256

Non-specific low back pain.

Federico Balagué1, Anne F Mannion, Ferran Pellisé, Christine Cedraschi.   

Abstract

Non-specific low back pain has become a major public health problem worldwide. The lifetime prevalence of low back pain is reported to be as high as 84%, and the prevalence of chronic low back pain is about 23%, with 11-12% of the population being disabled by low back pain. Mechanical factors, such as lifting and carrying, probably do not have a major pathogenic role, but genetic constitution is important. History taking and clinical examination are included in most diagnostic guidelines, but the use of clinical imaging for diagnosis should be restricted. The mechanism of action of many treatments is unclear, and effect sizes of most treatments are low. Both patient preferences and clinical evidence should be taken into account for pain management, but generally self-management, with appropriate support, is recommended and surgery and overtreatment should be avoided.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21982256     DOI: 10.1016/S0140-6736(11)60610-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  403 in total

1.  How well do observed functional limitations explain the variance in Roland Morris scores in patients with chronic non-specific low back pain undergoing physiotherapy?

Authors:  F Caporaso; N Pulkovski; H Sprott; A F Mannion
Journal:  Eur Spine J       Date:  2012-03-20       Impact factor: 3.134

2.  [Chronic low back pain : Comparison of mobilization and core stability exercises].

Authors:  M Alfuth; D Cornely
Journal:  Orthopade       Date:  2016-07       Impact factor: 1.087

3.  Complementary and integrative healthcare for patients with mechanical low back pain in a U.S. hospital setting.

Authors:  Taeho Greg Rhee; Brent D Leininger; Neha Ghildayal; Roni L Evans; Jeffery A Dusek; Pamela Jo Johnson
Journal:  Complement Ther Med       Date:  2015-11-25       Impact factor: 2.446

4.  Alterations in endogenous opioid functional measures in chronic back pain.

Authors:  Ilkka K Martikainen; Marta Peciña; Tiffany M Love; Emily B Nuechterlein; Chelsea M Cummiford; Carmen R Green; Richard E Harris; Christian S Stohler; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

5.  Mechanical demands on the lower back in patients with non-chronic low back pain during a symmetric lowering and lifting task.

Authors:  Iman Shojaei; Elizabeth G Salt; Quenten Hooker; Babak Bazrgari
Journal:  J Biomech       Date:  2017-07-05       Impact factor: 2.712

Review 6.  Yoga for chronic low back pain: a meta-analysis of randomized controlled trials.

Authors:  Susan Holtzman; R Thomas Beggs
Journal:  Pain Res Manag       Date:  2013-07-26       Impact factor: 3.037

7.  Cell-Seeded Adhesive Biomaterial for Repair of Annulus Fibrosus Defects in Intervertebral Discs.

Authors:  Michelle A Cruz; Warren W Hom; Tyler J DiStefano; Robert Merrill; Olivia M Torre; Huizi A Lin; Andrew C Hecht; Svenja Illien-Junger; James C Iatridis
Journal:  Tissue Eng Part A       Date:  2018-01-11       Impact factor: 3.845

Review 8.  An understanding of intervertebral disc development, maturation and cell phenotype provides clues to direct cell-based tissue regeneration therapies for disc degeneration.

Authors:  Ricardo Rodrigues-Pinto; Stephen M Richardson; Judith A Hoyland
Journal:  Eur Spine J       Date:  2014-04-29       Impact factor: 3.134

Review 9.  Chronic low back pain: a mini-review on pharmacological management and pathophysiological insights from clinical and pre-clinical data.

Authors:  Thomas S W Park; Andy Kuo; Maree T Smith
Journal:  Inflammopharmacology       Date:  2018-05-12       Impact factor: 4.473

10.  The enduring impact of what clinicians say to people with low back pain.

Authors:  Ben Darlow; Anthony Dowell; G David Baxter; Fiona Mathieson; Meredith Perry; Sarah Dean
Journal:  Ann Fam Med       Date:  2013 Nov-Dec       Impact factor: 5.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.